Elsevier

Journal of Molecular Liquids

Volume 342, 15 November 2021, 117537
Journal of Molecular Liquids

Solubility study of carvedilol in the aqueous mixtures of a choline chloride/propylene glycol deep eutectic solvent

https://doi.org/10.1016/j.molliq.2021.117537Get rights and content

Highlights

  • Solubility of carvedilol in choline chloride/propylene glycol deep eutectic solvent + water.

  • Correlation/back-calculation of the solubility data by some cosolvency models.

  • Calculation of thermodynamic parameters by using the van’t Hoff and Gibbs equations.

Abstract

Solubility behavior of a poorly soluble drug (carvedilol) has been studied in the aqueous mixtures of a deep eutectic solvent composed of choline chloride and propylene glycol at different temperatures (293.15–313.15) K. The obtained solubility data are correlated using some of the well-known cosolvency models such as the van’t Hoff, the mixture response surface, the Yalkowsky, the Jouyban-Acree, the Jouyban-Acree-van’t Hoff, and the modified Wilson models. The accuracy of these mathematical models is investigated with the mean relative deviations of the back calculated solubility data. The apparent thermodynamic properties (i.e. Gibbs energy, enthalpy and entropy) of carvedilol in the investigated mixtures are also calculated with the van’t Hoff and Gibbs equations at Thm.

Introduction

Carvedilol (CVD, 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy) ethylamino] propan-2-ol, C24H26N2O4, Fig. 1), is a beta blocker drug used for the treatment of mild and severe congestive heart failure [1]. CVD also possesses α1-adrenoreceptor blocking, vasodilatory and antioxidant activities. This drug shows its action mechanism as a competitive beta blocker at lower concentrations, whereas it is also Ca2+ channel antagonist at higher concentrations [2]. This racemic lipophilic aryloxy-propanol amine drug belongs to BCS class II with poor aqueous solubility and low oral bioavailability (25%) [3]. The oral bioavailability of CVD can be improved by increasing its solubility in neat solvents and/or combinations of cosolvents with water. So far, many solubility enhancement techniques like self-emulsifying drug delivery systems [4], [5], [6], cosolvency [7], [8], carrier and complexation [9], [10], [11], [12], enzymes and surfactant [13], ionic liquid formation [14], drug nanoparticle formation [15], solid dispersions [16], [17], [18], nanocrystals [19], [20], and pH adjustment [21] have been developed to improve the solubility of CVD and reported in the literatures. Among them, cosolvency is a simple and the most commonly used technique in the pharmaceutical industry. In this technique, the great difference in polarity of the poorly soluble drug molecules and water being decreased by using water miscible organic solvents [22]. Deep eutectic solvents (DESs) are a new type of green solvents, which are formed between at least two organic compounds (hydrogen bond acceptor (HBA) and a hydrogen bond donor (HBD)). In DESs, quaternary ammonium salt is usually selected as a HBA and it is complexed with an HBD like alcohols, amines, amides or carboxylic acids [23]. DESs have considerable attention owing to their unique physicochemical properties such as thermal stability, low vapor pressure, non-flammability, ease of preparation, normally biodegradable and colorlessness of most of them. Compared to ionic liquids and common organic solvents, DESs are considerably less toxic [24]. Furthermore, DESs have a high solubilization capability especially for poorly water-soluble drugs [25]. Some of reports for using DESs as cosolvent are solubilzation of lamotrigine [26], mesalazine [27], naproxen [28], [29], acetaminophen [30], cefixime [31], and allopurinol [32]. Up to now, there are a few reports on the solubility of CVD in different pure solvent and co-solvency systems [7], [8]. In order to the extension of the database for CVD solubility, we investigated its solubility profile in the aqueous mixtures of a DES as a green solvent. As we know, there is no report for the solubility of CVD in the DES composed of choline chloride (ChCl) and propylene glycol (PG) at different temperatures. The main aim of this research is to determine the solubility of CVD in the ChCl/PG-DES and water at different temperatures (293.15–313.15) K, correlate the experimental solubility data with some mathematical models and calculate thermodynamic parameters for CVD dissolution in these mixtures.

Section snippets

Materials

CVD (mass fraction purity of 0.992, Farabi Pharmaceutical Co., Iran), PG with a mass fraction purity of >0.995 (Scharlau Chemie, Spain), and ChCl with a mass fraction purity of >0.99 (Daejung, Korea) are used for the preparation of saturated mixtures in these experiments. Ethanol with a mass fraction purity of 0.935 (Jahan Alcohol Teb, Iran) is used for diluting the saturated solutions before spectrophotometric measurements.

Preparation of ChCl/PG DES

The essential amounts of ChCl is dried in an oven at 60 °C for 8 h.

Solubility behavior of CVD in the ChCl/PG -DES and water mixtures

The mean solubility data (in the molar solubility unit) of CVD in each solvent composition of the investigated mixtures measured at five temperatures of (293.2–313.2) K along with the standard deviation of replicated experimental results are listed in Table 1. Results show that the solubility of CVD increased with an increase of both mass fraction of DES and temperature. Further, as a visual summary, Fig. 2 depicts the CVD solubility expressed in the molarity unit as a function of both

Conclusions

The solubility profile of CVD in the ChCl/PG DES + water binary mixtures at different temperatures (293.15–313.15) K is investigated and the results show that CVD solubility is a function of temperature and DES mass fraction and increase with both increasing. The generated data are correlated with some linear and non-linear cosolvency models and the MRDs% of the back-calculated solubility data with all correlative models are <12.0 which are in the acceptable error levels and lies in the range

CRediT authorship contribution statement

Taher Sayad: Investigation, Funding acquisition. Kader Poturcu: Writing – original draft. Milad Moradi: Investigation, Formal analysis. Elaheh Rahimpour: Investigation, Writing – original draft, Project administration. Hongkun Zhao: Writing – review & editing. Abolghasem Jouyban: Writing – review & editing, Supervision, Funding acquisition.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

The authors would like to thanks Tabriz University of Medical Sciences for supporting this project under grant number of 65523.

References (40)

  • W. Li et al.

    Solubility modelling and thermodynamic properties of allopurinol in aqueous solutions of four deep eutectic solvents

    J. Chem. Thermodyn.

    (2019)
  • Marko Rogošić et al.

    Deep eutectic solvent based on choline chloride and propylene glycol as a potential medium for extraction denitrification of hydrocarbon fuels

    Chem. Eng. Res. Design

    (2020)
  • Allison B. Ochsner et al.

    Prediction of xanthine solubilities using statistical techniques

    J. Pharm. Sci.

    (1985)
  • Abolghasem Jouyban et al.

    Mathematical derivation of the Jouyban-Acree model to represent solute solubility data in mixed solvents at various temperatures

    J. Mol. Liq.

    (2018)
  • G.L. Perlovich et al.

    Thermodynamics of solutions: II. Flurbiprofen and diflunisal as models for studying solvation of drug substances

    Eur. J. Pharm. Sci.

    (2003)
  • R.R. Ruffolo, G.Z. Feuerstein, Carvedilol, in: Comprehensive Medicinal Chemistry II, Elsevier, USA, 2007, pp....
  • R.R. Ruffolo et al.

    The pharmacology of carvedilol

    Eur. J. Clin. Pharmacol

    (1990)
  • Bhupinder Singh et al.

    Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential

    Drug Deliv.

    (2011)
  • Anayatollah Salimi et al.

    Design and evaluation of self-emulsifying drug delivery system (SEDDS) of carvedilol to improve the oral absorption, Jundishapur

    J. Nat. Pharm. Prod.

    (2014)
  • V.M. Krishna et al.

    In-situ intestinal absorption and pharmacokinetic investigations of carvedilol loaded supersaturated self-emulsifying drug system

    Pharm, Nanotechnol.

    (2020)
  • Cited by (16)

    • Deep eutectic solvents based on sugars for oral applications

      2023, European Journal of Pharmaceutics and Biopharmaceutics
    View all citing articles on Scopus
    View full text